Publication – Page 2 – The He Group 贺晓鹏团队

5 03, 2026

Targeted metabolic glycoengineering using multivalent mannosyl metal–organic frameworks (MOFs)

Pei-Hong Tong^†, Chen Guo^†, Xi-Le Hu, Tony D. James*, Jia Li* and Xiao-Peng He*

Mater. Horiz. 2026, 13, 4450-4457. 10.1039/d5mh01986a

4 02, 2026

Protein-encapsulated fluorogenic probes for the selective detection of endogenous O-GlcNAcase (OGA)

Yuan-Hao Wu, Chen Guo, Zi-Ru Ye, Xi-Le Hu, Tony D. James*, Jia Li* and Xiao-Peng He*

Chem. Sci. 2026, 17, 7178-7184. 10.1039/d5sc06843f

3 01, 2026

Imaging of Lipid Droplets in Living Cells and Mice with Metabolic Dysfunction-Associated Steatotic Liver Disease via a Galactose-Modiﬁed Supramolecular Near-Infrared Fluorescent Glycoprobe

Han-Min Wang, Lei Dong, Qiu-Lian Hao, Lu-Lu Sun, Xin-Rong Li, Yu-Wei Yuan, Ming-Ye Tang, Jin Gong*, Yi Zang*, Jia Li*, Tony D. James*, Xiao-Peng He*, and Hai-Hao Han*

Adv. Funct. Mater. 2026, e25887. 10.1002/adfm.202425887

2 01, 2026

Decoding the function of the human glycome using chemical glycoprobes and glycosensor arrays

Xiao-Peng He

Chem. Soc. Rev. 2026, 55, 605-618. 10.1039/D5CS01177A

1 01, 2026

Antibacterial biomaterials: disruption of antibiotic tolerance for resistance prevention

Ming-Kai Wang, Jian Wang, Fu-Xiao Wang, Xi-Le Hu, Xiao-Peng He*, Tony D. James*, Han Liu* and Jia-Can Su*

Coord. Chem. Rev. 2026, 550, 217368. 10.1016/j.ccr.2025.217368